Vertex Pharmaceuticals Inc. closed $108.22 short of its 52-week high ($519.88), which the company achieved on November 8th.

Vertex secures FDA approval for ALYFTREK and expands TRIKAFTA use, advances diabetes and kidney disease therapies, and ...

Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 1.52% on an annualized basis producing an ...

Innovative Industrial Properties Inc. 9% Cum. Conv. Redeem. Pfd. Series A-0.16% Digital Realty Trust Inc. 5.25% Cum. Conv. Pfd. Series J 0.19% Digital Realty Trust Inc. 5.2% Cum. Redeem.

People visit the booth of Johnson & Johnson at the China International Import Expo (CIIE) in Shanghai, China November 7, 2024. REUTERS/Andrew Silver/File Photo Johnson & Johnson said on Monday it ...

Growth stocks are getting hammered by soaring bond yields. First off, long-dated bond yields have taken a wrecking ball to ...